Table 1.
IMPAIRED-HPA | NL-HPA | Healthy subjects | P value: IMPAIRED-HPA vs. NL-HPA | P value: IMPAIRED-HPA vs. healthy subjects | |
---|---|---|---|---|---|
Cortisol (μg/dl) | |||||
Baseline | 5.6 ± 2.3 | 11.0 ± 4.4 | 10.9 ± 5.6 | <0.001 | <0.001 |
LDC stimulated | 17.1 ± 4.6 | 27.7 ± 6.7 | 28.1 ± 6.0 | <0.001 | <0.001 |
DHEA (ng/ml) | |||||
Baseline | 1.0 ± 0.7 | 3.3 ± 1.9 | 3.3 ± 2.2 | <0.001 | <0.001 |
LDC stimulated | 2.1 ± 1.7 | 7.6 ± 4.9 | 8.4 ± 4.8 | <0.001 | <0.001 |
DHEA-S (μg/dl) | |||||
Baseline | 24.78 ± 19.6 | 73.7 ± 77.1 | 96.5 ± 81.3 | <0.001 | <0.001 |
Baseline and LDC-stimulated serum cortisol, DHEA, and DHEA-S levels in three groups of subjects: those with IMPAIRED-HPA (impaired HPA function); those with normal HPA function (NL-HPA); and healthy subjects. Baseline serum cortisol, DHEA, and DHEA-S serum levels in patients with NL-HPA were similar to those of healthy subjects. The LDC-stimulated serum cortisol and DHEA levels in patients with NL-HPA were similar to those of healthy subjects.